Try our beta test site
1 study found for:    NCT01248949
Show Display Options
Rank Status Study
1 Completed A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
Conditions: Advanced Solid Tumors;   Advanced Recurrent Ovarian Tumors
Interventions: Drug: MEDI3617;   Drug: MEDI3617 + Bev Q3W Dose Escalation;   Drug: MEDI3617 + Bev Q2W Dose Escalation;   Drug: Optional Dose Expansion;   Drug: MEDI3617 + Weekly Pax Dose Escalation;   Drug: MEDI3617 + Pax & Carbo Q3W Dos Esc;   Drug: MEDI3617 + Gem & Carbo Q3W Dos Esc;   Drug: Advanced Recurrent Ovarian Tumors

Study has passed its completion date and status has not been verified in more than two years.